Fukushima A, Alrob OA, Zhang L, Wagg CS, Altamimi T, Rawat S, Rebeyka IM, Kantor PF, Lopaschuk GD. Acetylation and succinylation contribute to maturational alterations in energy metabolism in the newborn heart. Am J Physiol Heart Circ Physiol 311: H347-H363, 2016. First published June 3, 2016; doi:10.1152/ajpheart.00900.2015.-Dramatic maturational changes in cardiac energy metabolism occur in the newborn period, with a shift from glycolysis to fatty acid oxidation. Acetylation and succinylation of lysyl residues are novel posttranslational modifications involved in the control of cardiac energy metabolism. We investigated the impact of changes in protein acetylation/succinylation on the maturational changes in energy metabolism of 1-, 7-, and 21-day-old rabbit hearts. Cardiac fatty acid ␤-oxidation rates increased in 21-day vs. 1-and 7-day-old hearts, whereas glycolysis and glucose oxidation rates decreased in 21-day-old hearts. The fatty acid oxidation enzymes, long-chain acyl-CoA dehydrogenase (LCAD) and ␤-hydroxyacylCoA dehydrogenase (␤-HAD), were hyperacetylated with maturation, positively correlated with their activities and fatty acid ␤-oxidation rates. This alteration was associated with increased expression of the mitochondrial acetyltransferase, general control of amino acid synthesis 5 like 1 (GCN5L1), since silencing GCN5L1 mRNA in H9c2 cells significantly reduced acetylation and activity of LCAD and ␤-HAD. An increase in mitochondrial ATP production rates with maturation was associated with the decreased acetylation of peroxisome proliferator-activated receptor-␥ coactivator-1␣, a transcriptional regulator for mitochondrial biogenesis. In addition, hypoxiainducible factor-1␣, hexokinase, and phosphoglycerate mutase expression declined postbirth, whereas acetylation of these glycolytic enzymes increased. Phosphorylation rather than acetylation of pyruvate dehydrogenase (PDH) increased in 21-day-old hearts, accounting for the low glucose oxidation postbirth. A maturational increase was also observed in succinylation of PDH and LCAD. Collectively, our data are the first suggesting that acetylation and succinylation of the key metabolic enzymes in newborn hearts play a crucial role in cardiac energy metabolism with maturation.
The present study is the first showing that alterations in acetylation and succinylation control of metabolic enzymes contribute to the dramatic shift in cardiac energy metabolism from glycolysis to fatty acid ␤-oxidation seen during maturation. Our results suggest that lysine acetylation enhances cardiac fatty acid ␤-oxidation and inhibits glycolysis during maturation.
OVER 1% OF NEWBORNS ARE DIAGNOSED with congenital heart disease (CHD), with one-third of these needing surgery within the first months of life (36) . Despite the major advances in surgical procedures, an obligatory ischemic period and a suboptimal cardioprotection during surgery remain a primary cause of perioperative mortality (59) , leading to a late onset of heart failure (3, 20) . The energy substrate preference has a profound impact on the heart to adapt to a newborn environment (29) , as well as to ischemia (6) . As a result, alterations in cardiac substrate preference during maturation will influence the outcome of CHD patients undergoing surgical repairs. Furthermore, because a metabolic profile of immature hearts originally enables the heart to tolerate hypoxic and ischemic milieu better than that of adult hearts (32) , a metabolic approach to facilitating the unique energetics (i.e., with supplemented cardioplegia or metabolic modulators) may prevent the late onset of heart failure, as well as the ischemic insult following surgery in these disease patients.
The fetal heart is highly dependent on glycolysis and lactate oxidation as a source of energy production, whereas the adult heart uses fatty acids as a predominant energy substrate (31) . These metabolic characteristics in the fetal heart are partly attributable to a relatively low oxygen environment, low energy demands, and the circulating levels of energy substrate such as high lactate and low fatty acids (32) . Within days of birth, however, dramatic maturational changes occur in energy substrate metabolism, with a shift from glycolysis to fatty acid oxidation. While fatty acid oxidation increases shortly after birth, developmental maturation of glucose oxidation is much slower and can lead to a decreased cardiac ATP generation in the neonatal heart (30) . The mechanisms responsible for the switch in energy substrate preference result, in part, from a decrease in allosteric inhibition of fatty acids uptake, maturational changes in transcriptional factors controlling fatty acid ␤-oxidation, and possibly changes in posttranslational modification that control key enzymes of fatty acid ␤-oxidation (30, 34) .
Acetylation of lysyl residue (lysine acetylation) is a novel posttranslational modification that has recently been shown to be important in the regulation of energy metabolism (9, 61) . Numerous enzymes involved in glycolysis, glucose oxidation, fatty acid ␤-oxidation, the tricarboxylic acid cycle, and the electron transport chain can be acetylated on at least one lysyl residue, resulting in inhibition or activation of enzyme activity (57) . Lysine acetylation is reversibly regulated by the competing activities of acetyltransferase and deacetylases. General control of amino acid synthesis 5 like 1 (GCN5L1) has recently been identified as a mitochondrial acetyltransferase that plays an important role in mitochondrial protein acetylation, respiration, and metabolism (54) . On the other hand, protein deacetylation is mediated by NAD ϩ -dependent class III histone deacetylases, called sirtuins (SIRT). SIRT1 is a ubiquitously expressed nuclear deacetylase that regulates transcriptional genes involved in cardiac energy metabolism (43) . Another nuclear deacetylase, SIRT6, regulates glucose homeostasis via acetylation of hypoxia-inducible factor (HIF)-1␣ (65) . SIRT3 is a mitochondrial deacetylase that regulates the key enzymes involved in glucose and fatty acid ␤-oxidation (9) . In contrast, mitochondrial SIRT5 functions as a desuccinylase and demalonylase, rather than a deacetylase enzyme (42, 47) .
To date, conflicting information has been reported regarding the role of acetylation in regulating fatty acid ␤-oxidation enzymes. Zhao et al. and our group have demonstrated that acetylation of the fatty acid ␤-oxidative enzymes enoyl-CoA hydratase, 3-hydroxyacyl-CoA dehydrogenase (␤-HAD), and long-chain acyl-CoA dehydrogenase (LCAD) results in an activation of enzyme activity (1, 64) . In contrast, Hirschey et al. have suggested that deacetylation of LCAD via SIRT3 accelerates fatty acid ␤-oxidation rates (9) .
As noted above, cardiac fatty acid ␤-oxidation dramatically increases postbirth. The goal of this study was thus to determine if maturational changes of lysine acetylation, succinylation, and malonylation contribute to this dramatic increase in fatty acid ␤-oxidation, as well as a decrease in glycolysis and glucose oxidation.
MATERIALS AND METHODS
Animals. All animals were treated according to the guidelines of the Canadian Council on Animal Care, and all procedures on animals were approved by the University of Alberta Health Sciences Animal Welfare Committee. One-, 7-, 21-, and 42-day-old New Zealand White rabbits of either sex were obtained from Charles River Laboratories (Charles River, Quebec, Canada) and were used in this study.
Heart perfusion. One-, 7-, and 21-day-old rabbits were anesthetized with an intraperitoneal injection of pentobarbital sodium (60 mg/kg body wt), and hearts were retrogradely perfused with Krebs-Henseleit solution [2.5 mM Ca 2ϩ , 5 mM glucose, 0.4 mM palmitate prebound to 3% bovine serum albumin (BSA), and 1 mM lactate], as described previously (31) . Rabbit hearts in three age groups were initially perfused for 30 min without insulin, followed by a 30-min perfusion with 100 U/ml insulin. The 2.5 mM Ca 2ϩ was determined based on the large requirement of Ca 2ϩ in the immature hearts, as previously described (15, 60) . Palmitate oxidation, glycolysis, lactate oxidation, and glucose oxidation rates were measured using radiolabeled [9, H]palmitate, [5- C]glucose, respectively, as described previously (16) . Steady-state rates of ATP production from exogenous substrates were calculated with the values of 2, 15, 31, and 105 mol ATP/mol of glucose produced from glycolysis, lactate oxidation, glucose oxidation, and palmitate oxidation, respectively (44) .
Immunoblot analysis. Thirty milligrams of frozen heart tissue were homogenized for 30 s with a Polytron homogenizer in buffer containing 0.05 M Tris·HCl, 0.15 M NaCl, 1% deoxycholic acid, 1% Nonidet P-40, 1% Triton X-100, 1 mM EDTA, and 0.1% sodium lauryl sulfate (SDS) in the presence of phosphatases and protease inhibitors (Sigma). Mitochondria, as well as nuclear and cytosol fractions, were also isolated and homogenized from the neonatal heart by the standard differential centrifugation method, as previously described (22) . Twenty micrograms of the denatured proteins were subjected to 5-12% SDS-PAGE and transferred to nitrocellulose membranes as previously described (62) . After blocking in 5% fat-free milk for 1 h, membranes were probed with the following antibodies: acetyl-lysine, phosphorylated pyruvate dehydrogenase (Ser 293 ), phospho-acetylCoA carboxylase (Millipore); malonyl-lysine and succinyl-lysine (PTM Biolabs); pyruvate dehydrogenase (PDH), AMP-activated protein kinase (AMPK), phospho-AMPK (Thr 172 ), voltage-dependent anion channel (VDAC) isoform 1, hexokinase I (HK-I), and phosphoglycerate mutase (PGM), transcriptional factor EB (TFEB) (Cell Signaling Technology); SIRT1, SIRT2, SIRT3, SIRT4, SIRT5, PDH kinase 4 (PDK4), peroxisome proliferator-activated receptor-␣ (PPAR␣), PPAR␥ coactivator-1␣ (PGC-1␣), ␤-HAD, LCAD, retinoid X receptor (RXR), estrogen-related receptor-␣ (ERR␣) (Abcam); SIRT6 (Sigma); ATP citrate synthase (Santa Cruz); HIF-1␣ (Novus Biologicals); carnitine acetyltransferase (CrAT) (Carbiochem); malonyl-CoA decarboxylase (MCD) (University of Alberta); and general control of amino acid synthesis 5 like 1 (GCN5L1) [generously provided by Dr. M. N. Sack, National Institutes of Health (NIH), Bethesda, MD]. Membranes were incubated with the appropriate secondary antibodies (Santa Cruz) for 1 h. These bands were visualized with enhanced chemiluminescence and quantified with Image J software (NIH). Ponceau red staining (Sigma) was used to normalize for any variation in protein loading between samples. In brief, multiple significant bands of Ponceau staining in each lane were all quantified by measuring integral under the entire density profile, as previously described (51) . This method can avoid potential problems associated with quantification of a single band for use as a loading control.
Immunoprecipitation. A total of 100 g of lysates was precleared with 20 l of protein A/G-agarose beads. The lysates were incubated with acetyl-lysine antibodies (3 g/100 g lysate; Millipore) overnight at 4°C, and 50 l of protein A-agarose beads were added to each sample and incubated on a rotator for 6 h at 4°C. After 6 h, samples were washed three times and centrifuged at 16,000 g for 5 min. The immune complexes were then subjected to immunoblot analysis as described above. Positive control of immunoprecipitation was the same samples without incubation with agarose beads and antibody. As a negative control, lysates were immunoprecipitated with normal rabbit IgG (Santa Cruz) coupled to agarose A/G beads or agarose A/G beads alone. The extent of acetylation protein was quantitated by calculating the ratio of acetylated protein/total protein band intensities.
␤-HAD, LCAD, and CrAT assays. ␤-HAD activity was assayed in total heart lysates prepared from frozen heart tissues, as previously described (62) . In brief, heart lysates were pipetted in a 96-well plate containing assay buffer. The reaction was initiated by the addition of acetoacetyl-CoA, and the absorbance was followed at 340-nm wavelength for 5 min.
LCAD activity was assayed as previously described (1) . In brief, 20 g of homogenate were pipetted in a 96-well plate containing potassium phosphate assay buffer. The reaction was initiated by the addition of palmitoyl-CoA (50 M), and the activity was followed spectrophotometrically at 300 nm wavelength for 2 min.
CrAT activity was assayed spectrophotometrically using a 5,5=-dithion-bis-2-nitrobenzoic acid (DTNB) reaction at 412 nm absorbance, as previously described (55) . The reaction mixture contained 0.1 M Tris·HCl (pH 8.0), 125 M DTNB, 0.1 mM acetyl-CoA, 1.1 mM L-carnitine, and an aliquot of the enzyme source. Enzyme activities were normalized for milligram protein content.
Measurements of CoA esters. Acetyl-CoA, succinyl-CoA, and malonyl-CoA levels were determined after tissue extraction from frozen heart tissue using 6% perchloric acid and assayed using a modified high-pressure liquid chromatography procedure, as described previously (34) .
Cell culture and transfection. The embryonic rat heart-derived H9c2 cells (American Type Culture Collection, Rockville, MD) were cultured in Dulbecco's modified Eagle's medium (Sigma) with 10% (vol/vol) fetal bovine serum and 1% (wt/vol) PenStrep (Sigma). For transient transfection, the H9c2 cardiomyoblasts were seeded in a six-well plate at a density of 2.0 ϫ 10 5 cells/well and transfected 24 h later with 50 nM of control scrambled or small-interfering RNA (siRNA) against GCN5L1 (Dharmacon) using DharmaFECT reagent (Dharmacon) according to the instructions of the manufacturer. Fortyeight hours after the transfection, Western blot analyses were performed to confirm the knockdown of targeted proteins.
Measurements of fatty acid oxidation rates in vitro. Oleate oxidation rates were measured in control or GCN5L1 siRNA-transfected H9c2 cells grown in T25 flasks as previously described (7) . Briefly, cell culture medium was switched to Krebs-Henseleit buffer containing (in mM) 118 NaCl, 4. Statistical analysis. Data are represented as means Ϯ SE. Comparisons were performed using a one-way ANOVA followed by Tukey's multiple-comparison test whenever differences were detected. Correlations were examined by linear regression analysis using the leastsquares method. Differences were considered significant at P Ͻ 0.05.
RESULTS
Metabolic profile in the newborn heart. Cardiac fatty acid oxidation rates markedly increased in 21-day-old compared with 1-day-old rabbit hearts (Fig. 1A) . In contrast, glycolytic rates significantly decreased at 7 and 21 days postbirth compared with 1-day-old hearts (Fig. 1B) . Lactate oxidation rates initially increased and then declined in 21-day compared with 7-day-old hearts (Fig. 1C) . Glucose oxidation rates decreased in an age-dependent manner, which was significantly lower at 21 days than at 1 day postbirth (Fig.  1D ). Both total ATP and acetyl-CoA production rates were significantly elevated in 21-day-old hearts ( Fig. 1, E and F) . This elevation in ATP and acetyl-CoA production rates was . Dramatic increases in fatty acid oxidation and decreases in glycolysis, lactate, and glucose oxidation in 1-, 7-, and 21-day-old rabbit hearts. Hearts from 1-, 7-, and 21-dayold rabbits were subjected to an isolated Langendorff heart perfusion. Palmitate oxidation (A), glycolysis (B), lactate oxidation (C), glucose oxidation (D), calculated steady-state ATP production (E), and acetyl-CoA production (F) are shown; n ϭ 4 -6 for each group. Total ATP production rates (E) and total rates of tricarboxylic acid (TCA) cycle activity measured by an acetyl-CoA production (F) were compared among the three age groups. Values represent means Ϯ SE. *Significant difference (P Ͻ 0.05) vs. 1 day old; †significant difference vs. 7 days old.
primarily derived from an increase in fatty acid oxidation rates postbirth, which accounted for 89% of the total ATP production.
Myocardial protein acylation postbirth. To understand the potential role of lysine acylation in the maturational change in cardiac energy metabolism postbirth, we first examined the total protein acetylation, succinylation, and malonylation that occurred in the newborn rabbit hearts. The level of protein acetylation increased with maturation, with lysine acetylation being increased 2.3-fold relative to 1-day-old hearts ( Fig. 2A) . This increase in lysine acetylation was also observed in isolated mitochondria, as well as nucleus and cytosol from 21-day-old rabbit hearts ( Fig. 2A) . In contrast to the newborn hearts, the overall acetylation of myocardial proteins was not further increased in 42-day-old adult hearts relative to 21-dayold hearts (data not shown), indicating a potential association between protein acetylation and metabolic alterations during maturation. In addition, protein succinylation increased in both whole heart lysates and the mitochondria from 21-day-old rabbits compared with 1-day-old rabbits ( Fig. 2B ). Unlike the overall acetylation, the total protein succinylation was further increased in 42-day-old adult hearts compared with 21-day-old hearts ( Fig. 2B ). In contrast, there was no maturational change in cardiac protein malonylation (Fig. 2C) .
Lysine acetylation is a reversible reaction mediated by a diverse family of acetyltransferase and deacetylase enzymes (Fig. 2D ). Protein levels of the SIRT1 deacetylase initially increased in 7-day-old hearts and then declined markedly in 21-day-old hearts. Another nuclear deacetylase, SIRT6, decreased in 21-day-old compared with 1-day-old hearts. These decreases in nuclear deacetylases were consistent with the increase in overall nuclear acetylation in 21-day-old hearts ( Fig. 2A) . Cardiac protein expressions of SIRT2 and SIRT4 were both elevated in 21-day-old rabbits compared with 1-dayold rabbits. While the expression of the cardiac mitochondrial deacetylase SIRT3 tended to increase postbirth, the increase was not statistically significant. In contrast, expression of the mitochondrial acetyltransferase, GCN5L1, increased postbirth, which could explain the increase in overall acetylation seen in 21-day-old hearts compared with 1-day-old hearts ( Fig. 2A) .
Consistent with the increase in protein succinylation seen in 21-day-old hearts ( Fig. 2B ), a maturational decrease in the levels of SIRT5 expression was observed (Fig. 2D) , the major enzyme involved in lysine desuccinylation.
Acetylation and succinylation control of fatty acid oxidation enzymes. Because the maturational increase in cardiac fatty acid ␤-oxidation rates occurred in parallel with an increase in protein acetylation or succinylation, we examined the association between the acetylation or succinylation of fatty acid ␤-oxidation enzymes and their enzymatic activities. The level of cardiac ␤-HAD protein expression was greater in the hearts from 21-day than 1-day-old rabbits ( Fig. 3A) . Furthermore, the levels of ␤-HAD acetylation increased in 7-day and 21-day-old hearts, even when normalized for total ␤-HAD protein (Fig.  3B ). This increased acetylation was accompanied by a significant increase in ␤-HAD activity in 21-day-old hearts ( Fig.  3C) . Expression of LCAD, another fatty acid ␤-oxidation enzyme, was significantly elevated in 7-and 21-day-old hearts compared with 1-day-old hearts ( Fig. 3D) . Similar to what was observed with ␤-HAD, there was also an age-dependent increase in the acetylated LCAD-to-LCAD ratio (Fig. 3E) , associated with concomitant increase in LCAD activity (Fig. 3F) . Importantly, we also observed a strong positive correlation between acetylated levels of LCAD or of ␤-HAD and fatty acid ␤-oxidation rates (R 2 ϭ 0.69 and 0.34, respectively, P Ͻ 0.05), as well as LCAD or ␤-HAD activity (R 2 ϭ 0.53 and 0.45, respectively, P Ͻ 0.05) (Fig. 3 , G-J). In contrast, there was no significant correlation between LCAD expression and LCAD activity or palmitate oxidation rates (Fig. 3, G and H) . Collectively, our results suggest that maturational increases in acetylation of fatty acid ␤-oxidation enzymes could enhance their activities and therefore stimulate fatty acid oxidation rates in the newborn hearts.
Similar to acetylation control of LCAD, cardiac LCAD succinylation also increased with maturation, with the difference being statistically significant in hearts from 21-dayold rabbits compared with 1-day-old rabbits ( Fig. 3K ). The degree of LCAD succinylation was also positively related to its activity but not to total fatty acid oxidation rates (Fig. 3 , L and M).
Age-dependent changes in PGC-1␣ acetylation. PGC-1␣ is a key transcriptional cofactor involved in mitochondrial biogenesis and is also under acetylation control (41) . We thus determined whether alterations in the expression and acetylation of PGC-1␣ could contribute to the maturational increase in fatty acid oxidation in the newborn hearts. There were no age-dependent changes in the levels of cardiac PCG-1␣ protein expression (Fig. 4A) . However, acetylated PCG-1␣ levels were significantly decreased in 21-day compared with 1-day-old rabbit hearts (Fig. 4B ). Acetylated PGC-1␣ is reported to be modulated by nuclear acetyltransferase GCN5 (25) . SIRT6 can deacetylate and increase the acetyltransferase activity of GCN5 (5). We thus investigated the acetylation of GCN5 and its protein expression. GCN5 protein expression was lower in 21-day-old hearts than 1-and 7-day-old hearts (data not shown). Acetylated GCN5 normalized to total protein levels was significantly increased in 21-day-old hearts compared with 1-and 7-day-old hearts ( Fig. 4C ), suggesting the diminished nuclear acetyltransferase activity with maturation.
PPAR␣ is a transcriptional regulator of fatty acid ␤-oxidation enzymes together with PGC-1␣. As we expected, PPAR␣ protein levels were higher in hearts from 21-day-old rabbits compared with 1-day-old rabbits ( Fig. 4D ), which probably contributed to the increase in ␤-HAD and LCAD expression seen in these hearts. RXR forms a heterodimer with PPAR␣ that activates genes involved in cardiac fatty acid uptake and oxidation (46) . In addition, ERR␣ directly binds to the PGC-1␣-responsive regions of the fatty acid oxidation (11) . Neither ERR␣ nor RXR expression was altered with maturation ( Fig.  4, E and F) . Because recent study has proposed that TFEB, a master regulator of autophagy, can also alter mitochondrial biogenesis under GCN5L1 (53), we next examined the nuclear expression of TEFB in these hearts. Nuclear expression of TFEB dramatically decreased in 21-day-old hearts compared with 1-and 7-day-old hearts ( Fig. 4G) , suggesting that TFEB is inactivated with maturation, in accordance with an agedependent increase in GCN5L1 expression (Fig. 2D) .
Unlike the fatty acid oxidative enzymes, there were no differences among the three age groups in the expression of VDAC1, a channel in the outer mitochondrial membrane isoform 1, or citrate synthase, a tricarboxylic acid (TCA) cycle Fig. 2 . Overall cardiac protein acetylation, succinylation, and malonylation in subcellular compartments of newborn hearts and maturational alterations in sirtuins (SIRTs) and a mitochondrial acetyltransferase. Total protein acetylation (A), succinylation (B), and malonylation (C) in whole heart lysates, nuclear fraction, cytosol fraction, or isolated mitochondria from 1-, 7-, 21, and 42-day-old hearts. Densitometry was performed in the range of 25-100 kDa for A, B, and C normalized to protein across the same molecular mass range from Ponceau S-stained membranes, the nuclear protein histone H3, the cytosolic protein tubulin, or the mitochondrial protein voltage-dependent anion channel subunit 1 (VDAC1). Protein expressions of SIRT1, SIRT2, SIRT3, SIRT4, SIRT5, SIRT6, and general control of amino acid synthesis 5 like 1 (GCN5L1) in hearts from 1-, 7-, and 21-day-old hearts (D). Values represent means Ϯ SE; n ϭ 6 -8 each. *Significant difference (P Ͻ 0.05) vs. 1 day old; †significant difference vs. 7 days old. enzyme, and complex I, an electron transport chain enzyme (Fig. 4, H-J) . Acetylation control of glucose metabolic enzymes. Because glycolytic rates significantly declined in the heart postbirth ( Fig. 1B) , we investigated the role of age-dependent expression and acetylation status of glycolytic enzymes. Expression of HIF-1␣, a transcriptional factor involved in glycolytic enzyme expression, progressively declined with maturation (Fig. 5A) . Consistent with this, expression of the glycolytic enzyme HK-1 (a downstream target of HIF-1␣) also decreased in 7-and 21-day-old hearts compared with 1-day-old hearts (Fig. 5B ). In contrast, the level of HK-1 acetylation significantly increased in 21-day-old hearts compared with 1-day-old hearts (Fig. 5C) . PGM, another glycolytic enzyme, is also known to be regulated by acetylation (8) . Cardiac PGM acetylation markedly increased in 21-day-old compared with 1-day and 7-day-old rabbits, whereas protein expression of PGM was decreased following birth (Fig. 5, D and E) .
PDH is the rate-limiting enzyme for glucose oxidation and has recently been shown to be under acetylation and succinylation control (17, 38) . Western blot analysis showed that neither cardiac PDH expression, PDH acetylation, nor the ratios of PDH acetylation/PDH expression were different with maturation (Fig. 5, F and G) . In contrast, phosphorylation of PDH (at Ser 293 of the E1␣ subunit) was significantly increased in hearts from 21-day compared with 1-and 7-day-old rabbits ( Fig. 5H ), in parallel with an increase in PDK4 expression at 21 days postbirth (Fig. 5I) . Because phosphorylation of PDH decreases its activity, these findings are consistent with the low glucose oxidation rates seen in 21-day-old rabbit hearts. Of interest, the level of succinylated PDH was significantly elevated with age (Fig. 5J) , accompanied by a decrease in SIRT5 expression (Fig. 2B) , supporting the recent concept that lysine succinylation facilitates PDH activity through an E1␣ phosphorylation-independent manner (47) .
Maturational changes in allosteric inhibition of fatty acid oxidation. To further investigate the substrate of acylation in the heart, we measured actual levels of CoA esters. The levels of malonyl-CoA, a potent endogenous inhibitor of carnitine palmitoyltransferase-I (CPT-I), were significantly decreased in 21-day-old hearts compared with 1-day-old hearts (Fig. 6A) . In contrast, no difference was observed in acetyl-CoA levels with maturation (Fig. 6B) . Succinyl-CoA levels significantly decreased in 21-day-old hearts compared with 1-day-old hearts, consistent with the low glucose oxidation rates seen in the 21-day-old hearts (Fig. 6C) . Malonyl-CoA is degraded by MCD and is synthesized by acetyl-CoA carboxylase (ACC). ACC is in turn regulated by AMPK, which can phosphorylate and inhibit ACC (33) . MCD protein expression markedly increased in 21-day-old hearts ( Fig. 6E) , although CPT-I expression was not changed with maturation (Fig. 6D) . Moreover, ACC was significantly phosphorylated in 21-day-old hearts compared with 1-day-old hearts ( Fig. 6F) , which was closely associated with an increased phosphorylation of AMPK (Fig. 6H) . CrAT is highly enriched in the heart and the skeletal muscle, and reversibly converts acetyl-CoA to acetylcarnitine, permitting intracellular trafficking of acyl moieties (39) . Expression of CrAT and its activity were both increased at 7 and 21 days compared with 1 day postbirth (Fig. 6, I and J) .
Effect of GCN5L1 knockdown on acetylation and fatty acid oxidation in vitro. To further prove that the increase in mitochondrial GCN5L1 was closely associated with maturational increase in cardiac acetylation, thereby increasing activity of fatty acid ␤-oxidation enzymes, we conducted GCN5L1 knockdown experiments in H9c2 rat cardiomyocytes. The transfection of GCN5L1 siRNA in H9c2 cells reduced its protein expression by 78% compared with scrambled siRNA (Fig. 7A) , in conjunction with a significantly reduced overall protein acetylation (Fig. 7B ). More importantly, not only the acetylated levels of LCAD and ␤-HAD (Fig. 7, C and D) , but also the activities of LCAD and ␤-HAD (Fig. 7 , E and F), were significantly reduced following GCN5L1 knockdown, corroborating the concept that GCN5L1 is a key molecule modulating acetylation of myocardial fatty acid enzymes during maturation. In contrast, actual fatty acid oxidation rates were not affected by GCN5L1 knockdown (Fig. 7G) . These results indicate that, whereas increased acetylation of fatty acid ␤-oxidation enzymes and the subsequent increase in their activities are due, in part, to increased GCN5L1 expression, other factors such as GCN5-PGC-1␣ axis, transcriptional regulation of PPAR␣, and allosteric inhibition of MCD may also be critically involved in the maturational increase in cardiac fatty acid oxidation.
DISCUSSION
The present study provides a number of novel observations regarding the effects of acetylation on enzymes involved in fatty acid ␤-oxidation, glycolysis, and glucose oxidation during maturation of the newborn heart. First, there is an age-dependent increase in the overall acetylation of cardiac proteins along with an increase in mitochondrial acetyltransferase, GCN5L1. Second, increased acetylation of the fatty acid ␤-oxidative enzymes ␤-HAD and LCAD is associated with activity, and is positively correlated with increased fatty acid oxidation rates during cardiac maturation. Third, acetylation of PGC-1␣ significantly decreases postbirth, concomitant with an increase in PPAR␣, ␤-HAD, and LCAD expression, but not with the protein levels related to mitochondrial biogenesis. Fourth, acetylation of the glycolytic enzymes HK and PGM increase, which is associated with a decrease in glycolysis rates seen in 21-day-old hearts, whereas acetylation in PDH was unaltered. Finally, knockdown of GCN5L1 in H9c2 cells reduces both acetylation and activities of LCAD and ␤-HAD, as well as total protein acetylation. Collectively, these data suggest a specific role of increased lysine acetylation in regulating the cardiac energy metabolic changes during maturation.
It is well accepted that maturational alterations in energy substrate metabolism in the newborn heart occur, in part, as a consequence of dramatic alterations in the allosteric control of fatty acid ␤-oxidation and the changes in transcriptional regulators (14, 34) . Posttranslational protein lysine acylation (including acetylation, succinylation, and malonylation) has recently been recognized as an important posttranslational modification in various cellular processes, including energy metabolism (9, 42, 47) . Indeed, a number of lysine acetylation and succinylation sites have been identified, including the sites in fatty acid oxidation enzymes, LCAD and ␤-HAD, in mice with deletion of mitochondrial SIRT3 or SIRT5 (9, 47) . In concert with age-dependent increase in fatty acid oxidation, we demonstrate that the overall protein acetylation and succinylation, but not malonylation, are also age-dependently increased. GCN5L1 is a newly identified mitochondrial lysine acetyltransferase that counters the function of SIRT3 (54) . Based on the unaltered expression of SIRT3 but increased expression of GCN5L1, we propose that GCN5L1 may be a key modulator of protein acetylation in the heart during maturation. This notion is supported by our recent studies in which increased GCN5L1 contributes to an increase in acetylation of LCAD in obese mice with heart failure, which, in turn, enhances fatty acid oxidation rates (52) . As a proof of the concept, we further demonstrated that the inhibition of GCN5L1 in H9c2 cells via siRNA attenuated the levels of acetylated LCAD and ␤-HAD, as well as total protein acetylation, in parallel with suppressed activities of both enzymes. On the other hand, the increase in succinylation is possibly due to an age-dependent decrease in SIRT5 expression, since SIRT5 is shown to primarily function as a desuccinylase and/or demalonylase, as opposed to a deacetylase enzyme (42, 47) . Compared with overall acetylation that was no longer increased in adult hearts relative to 21-day-old hearts, the overall succinylation continued to increase even in adult hearts, implicating a distinct role of protein succinylation in cardiac metabolism in matured hearts. Unaltered total malonylated protein despite the decrease in SIRT5 expression is presumably due to decreased malonyl-CoA levels, a substrate of malonylation. It is worthy of note that fatty acid oxidation rates were not significantly affected by GCN5L1 knockdown in H9c2 cells. One of the possibilities could be that GCN5 and SIRT6-mediated deacetylation of PGC-1␣ potentially contributes to maturational increase in fatty acid oxidation, and inhibiting GCN5L1 alone may not be sufficient to suppress overall fatty acid oxidation rates. In addition, nuclear expression of TFEB was dramatically downregulated in 21-day-old hearts as opposed to an increase in GCN5L1 expression, suggesting that maturational alterations in mitochondrial biogenesis mediated by GCN5L1 are partly due to the suppression of mitochondrial degradation via autophagy through TFEB (53) . Collectively, the increase in overall acetylation is associated with the age-dependent increase in cardiac fatty acid oxidation, whereas GCN5L1 along with other factors contribute to this process during maturation.
One of the factors could be PGC-1␣, since its acetylation decreases in an age-dependent manner, accompanied by an increase in the expression of its transcriptional partner, PPAR␣. This decreased acetylation of PGC-1␣ did not affect the proteins related to mitochondrial biogenesis in the present study, but it could contribute to transcriptional activation of fatty acid oxidation enzymes, such as LCAD and ␤-HAD, as well as enhancement of mitochondrial biogenesis with maturation. Regarding the modulator of PGC-1␣ deacetylation, we propose that SIRT1 and SIRT6 may coordinate each other. In line with this, it has been shown that SIRT1 and SIRT6 coordinate the switch from glucose to fatty acid ␤-oxidation in response to an acute inflammation (27) . In addition, we observed that SIRT1 protein levels first increased at 7 days and then declined at 21 days (biphasic change). In contrast, a significant decrease in SIRT6 expression was evident in 21-day-old hearts compared with 1-day-old hearts. To get further insight, we also investigated GCN5, a nuclear acetyltransferase, as a downstream target of SIRT6 (5). Indeed, acetylated GCN5 was significantly increased in 21-day-old hearts, consistent with an increase in global nuclear acetylation, whereas GCN5 protein expression was decreased in 21-day-old hearts. One of the mechanisms for decreased protein expression of GCN5 could be due to its protein instability, resulting in GCN5 degradation. Further study is necessary to elucidate this mechanism. Moreover, SIRT2 is a cytoplasmic deacetylase, and reduced SIRT2 function directly represses deacetylation of PGC-1␣ and thereby inhibits fatty acid oxidation in adipocytes (21) . Increased cardiac expression of SIRT2 may also account for decreased acetylation of PGC-1␣.
On the other hand, other transcriptional cofactors, including ERR␣ and RXR, were not changed with maturation, although physiological interactions between acetylated PGC-1␣ and its cofactors remain largely elusive. The maturational increase in acetyl-CoA production due to fatty acid oxidation is another factor that contributes to increased protein acetylation. It has been shown that enhanced hepatic fatty acid oxidation occurred in conjunction with increase in mitochondrial and peroxisomal protein acetylation (49) .
A PPAR␣-induced increase in protein expression of LCAD, ␤-HAD, and MCD suggests its crucial role in energy metabolism in the neonatal hearts. Indeed, we recently showed that stimulating fatty acid oxidation (with a PPAR␣ agonist) improves cardiac energy production and postischemic functional recovery in volume overload-induced cardiac hypertrophy in neonatal rabbit hearts (22) . To clarify the specific role of PPAR␣ in the maturational metabolic shift in the newborn However, because of the small size of fetal hearts from PPAR␣-deficient mice, it is technically difficult to measure their cardiac energy metabolisms. On the other hand, mitochondrial deacetylase SIRT4 has recently been shown to deacetylate and inactivate MCD, resulting in the enhancement of fatty acid uptake and oxidation (23) . Consistent with increased fatty acid oxidation with maturation, increased cardiac expression of SIRT4 was observed in 21-day-old hearts.
With regard to what effects lysine acetylation have on fatty acid ␤-oxidation enzymes, there is not a consensus. Some studies suggest an inhibitory effect while others suggest a stimulatory effect. For instance, hyperacetylated LCAD has been suggested to reduce enzymatic activity in the liver and the heart from SIRT3-deficient mice (9, 19) , and LCAD Lys 42 , Lys 318 , and Lys 322 were detected as a critical active site for the regulation of LCAD enzymatic activity by SIRT3 (2, 4) . However, we have demonstrated that increased acetylation of LCAD and ␤-HAD is associated with an increase in fatty acid ␤-oxidation rates in hearts from mice with SIRT3 deficiency, as well as in mice with a high-fat diet-induced obesity, and in mice with heart failure (1, 52) . Because previous studies were carried out in males and similarly aged animals, gender or age effects are unlikely to occur in those experimental settings (1, 10, 52) . With regard to assay condition in LCAD activity, other groups applied the anaerobic electron transferring flavoprotein fluorescence reduction assay (2, 9, 10), whereas we performed a sensitive aerobic assay in which electron transferring flavoprotein is replaced by the ferricenium ion, a readily obtainable organometallic oxidant. However, both enzymatic assays are reported to provide comparable results in medium-chain acylCoA dehydrogenase-deficient patients (24) . On the other hand, some specific acetylation sites are shown to change the activity by modulating the conformation of the LCAD active site (2) . This suggests that the impact of LCAD acetylation on its activity is, at least in part, due to a site-specific manner, and, as such, the discrepant findings between acetylation and fatty acid ␤-oxidation might be explained by the difference in specific acetylation site controlling metabolic enzymes. Supporting our results, Zhao et al. showed that acetylation of the fatty acid ␤-oxidation enzyme enoyl-CoA hydratase/3-hydroxyacyl-CoA results in an activation of enzymatic activity in HEK 293 cells (64) . Furthermore, Vazquez et al. have recently reported that increased lysine acetylation contributes to the increased fatty acid oxidation rates in diabetic hearts (56) . Of importance, Lu et al. have demonstrated that increased acetylation of heat shock protein 10 can regulate folding of fatty acid oxidation enzymes in the SIRT3 knockdown cells, enhancing the enzymatic activity, and therefore increase fatty acid oxidation rates (35) . Collectively these findings suggest that increased acetylation of fatty acid oxidative enzymes is increasing fatty acid ␤-oxidation rates, and that this increased acetylation contributes to the dramatic maturational increase in myocardial fatty acid oxidation seen in the newborn period.
A number of glycolytic enzymes are acetylated, and inhibition of glycolysis is associated with a reduction in SIRT1 expression (26) . We showed that glycolysis rates markedly decline with maturation along with an increase in acetylation of the glycolytic enzymes HK and PGM. This is accompanied by a decrease in SIRT1 expression, suggesting that increased acetylation of these glycolytic enzymes inhibits glycolysis. In addition, a role for alterations in HIF-1␣ expression, a transcription factor that upregulates the expression of genes involved in glycolysis, may also contribute to this decrease in glycolysis. HIF-1␣ expression decreases postbirth (40), a finding confirmed in our study. Taken together, our data suggest that both a decrease in HIF-1␣ expression and an increase in acetylated glycolytic enzymes account for the decrease in glycolysis in the newborn heart.
PDH is a rate-limiting enzyme for glucose oxidation by which pyruvate flux in the TCA cycle is regulated (33) . Recent studies have shown that the activity of PDH is regulated by reversible acetylation, in addition to phosphorylation control, and that hyperacetylation of PDH inhibits enzyme activity in skeletal muscles, cancer cells, and the heart (17, 38) . However, we did not find that either PDH protein levels or its acetylation was altered during maturation, suggesting that mechanisms other than acetylation primarily regulate PDH activity during cardiac maturation. Lactate is an important fuel during maturation, since fetal hearts can readily extract and oxidize lactate (29) . We found that cardiac lactate oxidation is still high by 7 days postbirth although its oxidation rates significantly decrease in 21-day-old hearts. Because circulating lactate levels are very high in the fetus (29) , lactate oxidation accounts for the majority of myocardial oxygen consumption. Following birth, blood levels of lactate decrease significantly, and the contribution of lactate oxidation to ATP production in the neonatal period markedly decreases (16, 31) . Our study suggests that this decrease in lactate oxidation occurs secondary to an increase in PDH phosphorylation and not due to alterations in the acetylation of PDH. The increase in fatty acid oxidation may predominate and inhibit glucose oxidation during maturation (i.e., via the Randle cycle) (33) . Moreover, we also show that increased PPAR␣ expression via increased PGC-1␣ activity may upregulate PDK4 expression, resulting in hyperphosphorylation and inactivation of PDH during maturation.
PDK4-induced low-glucose oxidation rates in the newborn hearts are consistent with the cardiac insulin resistance due to the upregulation of PDK4 seen in agonist-induced hypertrophied hearts (38) . Because a hypertrophied heart is known to revert fetal metabolic phenotype, these common features in low-glucose oxidation due to PDK4 might cause an increase in cardiac fatty acid oxidation (i.e., via the Randle Cycle). Indeed, hearts from PDK4 transgenic mice are shown to exhibit a marked increase in fatty acid oxidation and a corresponding decrease in glucose oxidation (63) .
Recent studies on SIRT5-deficient animals have suggested that several metabolic pathways, including ketogenesis, glucose oxidation, and fatty acid ␤-oxidation, are hypersuccinylated, which can modify these pathways by altering their key enzymatic activities (47, 50) . In support of this, we show that both succinylated LCAD and PDH levels are significantly increased with maturation. However, neither succinylated LCAD nor PDH correlate with fatty acid or glucose oxidation rates, suggesting that lysine succinylation is not a major regulator of metabolic change in the newborn hearts.
Cellular acyl-CoA concentration can potentially impact lysine acylation. In particular, emerging data highlight the importance of mitochondrial acetyl-CoA levels as a major contributor to nonenzymatic acetylation in mitochondrial proteins, as well as a cofactor for acetyltransferase (37, 48) . Although we could not evaluate the mitochondrial acetyl-CoA levels in the current study, 95% of CoA, an essential cofactor for acetyl-CoA, is known to be localized to the mitochondria in terms of its overall intracellular content (12) . Furthermore, recent study showed that acetyl-CoA levels are 20-to 30-fold higher in mitochondria compared with the cytoplasm and nucleus, which correlates with mitochondrial acetylation (58) . Hence, the observed changes in global acetyl-CoA levels likely reflect changes within the mitochondrial compartment. Interestingly, despite a postnatal increase in total lysine acetylation and succinylation, acetyl-CoA levels were not changed, and succinyl-CoA levels were markedly decreased. Given that acetyl-CoA production was increased with maturation, steady-state acetyl-CoA levels would remain the same if its production rates were similar to that of utilization for acetylation. In addition, increased levels of CrAT expression and activity may help keep acetyl-CoA levels for age-dependent increase in lysine acetylation as well as energy demands with maturation because CrAT is shown to supply an acetyl buffer for working skeletal muscles during high workloads (55) . Decreased acetylation of PGC-1␣ due to increased acetylation of nuclear GCN5, in conjunction with increased SIRT1 and decreased SIRT6, can enhance cardiac fatty acid oxidation, which is in line with an increase in transcriptional regulation of PPAR␣ and a subsequent increase in LCAD and ␤-HAD. Mitochondrial GCN5L1-mediated acetylation of LCAD and ␤-HAD also promotes activation of these enzymes. A transcriptional regulator of glycolytic enzyme, HIF-1␣, and one of its downstream targets, HK-I, decrease postbirth, in concert with increased acetylation of PGM and HK-I, contributing to inhibit glycolysis following birth. Phosphorylated, and thereby inactivated, PDH is responsible for low glucose oxidation rates observed in the newborn heart. With regard to allosteric control, maturational increases in AMPK phosphorylation reduce malonyl-CoA levels in the heart, secondary to phosphorylation of ACC and along with a PPAR␣-induced elevation of MCD, which can facilitate fatty acid uptake in the heart postbirth. Gray arrows indicate increased or decreased with maturation.
Based on these results, we propose an important role of acetylation control in a dramatic maturational switch in cardiac energy metabolism besides our previous findings on allosteric and transcriptional regulation (Fig. 8) (18, 22, 45) . Decreased acetylation of PGC-1␣ via maturational change in SIRT1 and SIRT6, as well as via increased acetylation of GCN5, can enhance cardiac fatty acid oxidation, in concert with increase in transcriptional regulation of PPAR␣ and subsequent increase in LCAD and ␤-HAD. Furthermore, GCN5L1-mediated acetylation of LCAD and ␤-HAD also promotes activation of these enzymes. In addition to dramatic decrease in HIF-1␣ expression, increased acetylation of PGM and HK-I contributes to inhibit glycolysis following birth. Phosphorylated and thereby inactivated PDH is responsible for low glucose oxidation rates observed in the newborn heart. As for an allosteric control, we confirmed that a maturational increase in AMPK phosphorylation reduces malonyl-CoA levels in the heart, secondary to phosphorylation of ACC and along with PPAR␣-induced elevation of MCD, which can facilitate fatty acid uptake in the heart postbirth.
Limitations. First, although the present data implicate that acetylation of glycolytic enzymes and fatty acid ␤-oxidation enzymes can alter cardiac metabolic flux of those pathways, we could not determine the proportion of acetylated to nonacetylated proteins due to technical difficulties in assessing the quantitative proteomics. Second, SIRT1, SIRT3, and SIRT6 have been shown to be involved in cardiac hypertrophy. Hence, changes in SIRT levels could be influenced by the endogenous response against physiological hypertrophy, as well as metabolism with maturation. Third, plasma fatty acid concentration in human newborns is reported to be higher than the concentration of fatty acids that we used in the isolated heart perfusions (28). Because we previously reported that increasing fatty acid concentration from 0.4 to 2.4 mM palmitate does markedly increase fatty acid ␤-oxidation with little effect on glucose oxidation in isolated working hearts from 7-day-old rabbits (13), we speculate that the higher concentration of palmitate in perfusate will further enhance maturational increase in fatty acid oxidation in the present experimental settings. Finally, a gender effect on cardiac maturational change in energy metabolism cannot be completely excluded because of the difficulty in finding the definitive gender of newborn rabbits.
In conclusion, we demonstrate that decreased acetylation of PGC-1␣, and increased acetylation of ␤-HAD, LCAD, HK, and PGM, may account for the dramatic shift in cardiac energy metabolism from glycolysis to fatty acid ␤-oxidation seen during maturation. Our results suggest that lysine acetylation could enhance cardiac fatty acid ␤-oxidation and inhibit glycolysis during maturation. 
